Review



cd142 antibody  (Miltenyi Biotec)


Bioz Verified Symbol Miltenyi Biotec is a verified supplier
Bioz Manufacturer Symbol Miltenyi Biotec manufactures this product  
  • Logo
  • About
  • News
  • Press Release
  • Team
  • Advisors
  • Partners
  • Contact
  • Bioz Stars
  • Bioz vStars
  • 94

    Structured Review

    Miltenyi Biotec cd142 antibody
    Cd142 Antibody, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 31 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/CD142+Antibody%2C+anti-human/pmc12830222-7-0-3
    Average 94 stars, based on 31 article reviews
    cd142 antibody - by Bioz Stars, 2026-09
    94/100 stars

    Images

    Related Articles

    other:

    Article Title: Glioblastoma functional heterogeneity and enrichment of cancer stem cells with tumor recurrence
    Article Snippet: Mouse anti-CD142(F3) - FITC , Miltenyi Biotec , Cat# 130–098-854, RRID: AB_2655127.

    Article Title: Synthetic zipper mediated pre-targeting system for near-infrared photoimmunotherapy
    Article Snippet: CD142 Antibody , Miltenyi Biotec , 130-098-741; RRID: AB_2655142.

    Staining:

    Article Title: SNAP-Tag-Based Antibody–Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer Treatment
    Article Snippet: .. Briefly, 4 × 10 5 cells were collected and washed twice with PBS and then stained with anti-EGFR (H11, 0.5 μg, Thermo Fisher Scientific), anti-Trop2 (MR54, 1 μg, Thermo Fisher Scientific), or anti-TF (CD142, 10 μL, Miltenyi Biotec) antibodies in 200 μL of PBS for 30 min on ice. .. According to the manufacturer’s instructions, cells were fixed by 4% formaldehyde solution at room temperature for 10 min, followed by permeabilization with 0.1% Triton X-100 in TBS at room temperature for 5 min followed by a blocking step (10% FBS and 1% BSA in PBS) on ice for 30 min before incubation with the anti-Her2 antibody (3B5, 0.2 μg, Thermo Fisher Scientific), as the antibody binds to the intracellular domain of Her2.

    Article Title: A platelet transcriptomic signature of thromboinflammation predicts cardiovascular risk
    Article Snippet: Blood was collected without the use of a tourniquet and collected into tubes containing 3.2% sodium citrate (BD Vacutainer catalog 369714). .. Citrate-anticoagulated whole blood was fixed with 1% formalin (Crystalgen catalog CG-190), and stained with CD61 FITC (Agilent DAKO item #F0803), CD86 PE (catalog 555665), CD40 V450 (catalog 561219) (BD), CD14 PE Vio770 (catalog 130-110-521), CD45 VioGreen (catalog 130-110-638), CD16 APC Vio770 (catalog 130-113-390), CD11 APC (catalog 130-110-554), CD162 APC (catalog 130-123-841), and CD142 VioBlue (catalog 130-098-921) (Miltenyi Biotec), followed by lysis of red blood cells. ..

    Article Title: Near-infrared photoimmunotherapy for effective elimination of ovarian cancer cells by inducing immunogenic cell death
    Article Snippet: .. The slides were stained with anti-Her2 antibody (ErbB2 mAb, 3B5, 1:500, Invitrogen, #MA5-13675), anti-TF antibody (CD142 mAb, clone HTF-1, 10 μL, Miltenyi Biotec, #130-098-741), anti-EGFR antibody (Sigma-Aldrich, 1:200, #HPA018530), and anti-TROP2 antibody (TROP2 mAb, clone MR54, 1:100, Invitrogen, #14-6024-82), followed by incubation with secondary antibody (anti-mouse or anti-rabbit according to primary antibody). .. After that the sections were incubated with Alexa Fluor 488 Tyramide (Invitrogen, B40953 ), Alexa Fluor 546 Tyramine (Invitrogen, B40954 ), Alexa Fluor 647 Tyramide (Invitrogen, B40958 ), iFluor 750 Styramide (AAT Bioquest, #45065) according to the abovementioned procedure.

    Lysis:

    Article Title: A platelet transcriptomic signature of thromboinflammation predicts cardiovascular risk.
    Article Snippet: .. 1 1 C L I N I C A L R E S E A R C H A N D P U B L I C H E A L T H JCI Insight 2025;10(24):e195824 https://doi.org/10.1172/jci.insight.195824 VioBlue (catalog 130-098-921) (Miltenyi Biotec), followed by lysis of red blood cells. ..

    Article Title: A platelet transcriptomic signature of thromboinflammation predicts cardiovascular risk
    Article Snippet: Blood was collected without the use of a tourniquet and collected into tubes containing 3.2% sodium citrate (BD Vacutainer catalog 369714). .. Citrate-anticoagulated whole blood was fixed with 1% formalin (Crystalgen catalog CG-190), and stained with CD61 FITC (Agilent DAKO item #F0803), CD86 PE (catalog 555665), CD40 V450 (catalog 561219) (BD), CD14 PE Vio770 (catalog 130-110-521), CD45 VioGreen (catalog 130-110-638), CD16 APC Vio770 (catalog 130-113-390), CD11 APC (catalog 130-110-554), CD162 APC (catalog 130-123-841), and CD142 VioBlue (catalog 130-098-921) (Miltenyi Biotec), followed by lysis of red blood cells. ..

    Incubation:

    Article Title: Near-infrared photoimmunotherapy for effective elimination of ovarian cancer cells by inducing immunogenic cell death
    Article Snippet: .. The slides were stained with anti-Her2 antibody (ErbB2 mAb, 3B5, 1:500, Invitrogen, #MA5-13675), anti-TF antibody (CD142 mAb, clone HTF-1, 10 μL, Miltenyi Biotec, #130-098-741), anti-EGFR antibody (Sigma-Aldrich, 1:200, #HPA018530), and anti-TROP2 antibody (TROP2 mAb, clone MR54, 1:100, Invitrogen, #14-6024-82), followed by incubation with secondary antibody (anti-mouse or anti-rabbit according to primary antibody). .. After that the sections were incubated with Alexa Fluor 488 Tyramide (Invitrogen, B40953 ), Alexa Fluor 546 Tyramine (Invitrogen, B40954 ), Alexa Fluor 647 Tyramide (Invitrogen, B40958 ), iFluor 750 Styramide (AAT Bioquest, #45065) according to the abovementioned procedure.



    Similar Products

    94
    Miltenyi Biotec monoclonal human cd142 antibody conjugated to apc
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Monoclonal Human Cd142 Antibody Conjugated To Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/CD142+Antibody%2C+anti-human/pmc13208649-57-0-9
    Average 94 stars, based on 1 article reviews
    monoclonal human cd142 antibody conjugated to apc - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Bioss rabbit anti human tissue factor antibody
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Rabbit Anti Human Tissue Factor Antibody, supplied by Bioss, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/CD142+Polyclonal+Antibody/pmc13124779-45-42-48
    Average 94 stars, based on 1 article reviews
    rabbit anti human tissue factor antibody - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Sino Biological monkey
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Monkey, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/Cynomolgus+Coagulation+Factor+III+%2F+Tissue+Factor+%2F+CD142+Protein/10__1158_slash_1535___7163__mct___26___0045-50-12-13
    Average 94 stars, based on 1 article reviews
    monkey - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    93
    Sino Biological cynomolgus monkey
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Cynomolgus Monkey, supplied by Sino Biological, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/Human+Coagulation+Factor+III+%2F+Tissue+Factor+%2F+CD142+Protein/10__1158_slash_1535___7163__mct___26___0045-50-11-13
    Average 93 stars, based on 1 article reviews
    cynomolgus monkey - by Bioz Stars, 2026-09
    93/100 stars
      Buy from Supplier

    94
    Sino Biological ab t02
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Ab T02, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/Mouse+Coagulation+Factor+III+%2F+Tissue+Factor+%2F+CD142+Protein/10__1158_slash_1535___7163__mct___26___0045-50-29-22
    Average 94 stars, based on 1 article reviews
    ab t02 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Sino Biological recombinant human cd71
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Recombinant Human Cd71, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/Human+Coagulation+Factor+III+%2F+Tissue+Factor+%2F+CD142+Protein/pm41986718-822-0-12
    Average 94 stars, based on 1 article reviews
    recombinant human cd71 - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Sino Biological human cd142 13133 h02h proteins
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Human Cd142 13133 H02h Proteins, supplied by Sino Biological, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/Human+Coagulation+Factor+III+%2F+Tissue+Factor+%2F+CD142+Protein/pm41986718-822-5-12
    Average 94 stars, based on 1 article reviews
    human cd142 13133 h02h proteins - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    R&D Systems cd142 anti htf
    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with <t>anti-CD142</t> (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.
    Cd142 Anti Htf, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/Human+Coagulation+Factor+III%2FTissue+Factor+Antibody/pmc12993400-12-0-3
    Average 94 stars, based on 1 article reviews
    cd142 anti htf - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec anti tf
    Different expression in ovarian cancer cell lines. The expression levels of EGFR, Trop2, TF, and Her2 in ovarian cancer cell lines were determined by flow cytometry. The cells were treated with anti-EGFR (EGFR monoclonal antibody, H11), anti-Trop2 (Trop2 monoclonal antibody, <t>MR54),</t> <t>anti-TF</t> <t>(CD142</t> antibody), and anti-Her2 (ErbB2 monoclonal antibody, 3B5) antibodies, respectively, followed by incubation with a secondary antibody (Goat anti-Mouse IgG Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 647). The cells were permeabilized to determine the Her2 expression according to manufacturer’s instructions.
    Anti Tf, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/CD142+Antibody%2C+anti-human/pmc13019189-70-32-36
    Average 94 stars, based on 1 article reviews
    anti tf - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    94
    Miltenyi Biotec cd142 antibody, anti-human
    Different expression in ovarian cancer cell lines. The expression levels of EGFR, Trop2, TF, and Her2 in ovarian cancer cell lines were determined by flow cytometry. The cells were treated with anti-EGFR (EGFR monoclonal antibody, H11), anti-Trop2 (Trop2 monoclonal antibody, <t>MR54),</t> <t>anti-TF</t> <t>(CD142</t> antibody), and anti-Her2 (ErbB2 monoclonal antibody, 3B5) antibodies, respectively, followed by incubation with a secondary antibody (Goat anti-Mouse IgG Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 647). The cells were permeabilized to determine the Her2 expression according to manufacturer’s instructions.
    Cd142 Antibody, Anti Human, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
    https://www.bioz.com/product/cd142/CD142+Antibody%2C+anti-human/custom%40130-098-853%4010%2E1016%2Fj%2Eisci%2E2025%2E114558
    Average 94 stars, based on 1 article reviews
    cd142 antibody, anti-human - by Bioz Stars, 2026-09
    94/100 stars
      Buy from Supplier

    Image Search Results


    Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with anti-CD142 (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.

    Journal: Life

    Article Title: Ice-Cold Temperature Enhances NADPH Oxidase-Dependent Release of Tissue Factor-Bearing Extracellular Vesicles from Human Monocytic Cells

    doi: 10.3390/life16050820

    Figure Lengend Snippet: Distinct localization of tissue factor and phosphatidylserine on vesicles, with identification of TF-bearing vesicles within the microvesicle size range. ( A ) Suspension of THP-1 cells shown in the plot of side scatter (SSC) versus forward scatter (FSC). Cells were incubated at 4 °C for 24 h, followed by rewarming at 37 °C for 1 h, and then subjected to flow cytometry after staining with anti-CD142 (tissue factor) antibody conjugated with APC and Annexin V–FITC. ( B ) Same as ( A ), shown with a logarithmic FSC scale. Gating strategy, including the identification of CountBright beads and microvesicle-sized particles (MV), was defined as described in . ( C ) APC fluorescence versus FSC from particles in the THP-1 cell suspension derived from the same sample as in ( A , B , E , F ), without staining with anti-CD142 antibody or Annexin V, showing background APC fluorescence. ( D ) FITC fluorescence versus FSC from the same cell suspension as in ( C ), showing background FITC fluorescence. ( E ) APC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( F ) FITC fluorescence versus FSC from the same cell suspension as in ( A , B ). ( G ) FSC–SSC plot obtained from size-calibration beads for microvesicles (Megamix) mixed with 1 vol% CountBright beads, used to define the gate for microvesicle-sized particles (MV). ( H ) FSC–SSC plot obtained from culture medium containing 2 mM CaCl 2 . ( I ) APC fluorescence versus FITC fluorescence from the same cell suspension as in ( A , B , E , F ), with analysis restricted to particles gated as MV. ( J ) FSC–SSC plot of particles in the suspension derived from the same sample as in ( A , B , E , F ) after centrifugation at 2400× g for 1 min. ( K ) The suspension in ( J ) was further centrifuged at 12,000× g for 15 min to sediment vesicles. FSC–SSC plot of particles in the pellet resuspended in filtered culture medium containing 2 mM Ca 2+ and incubated with anti-CD142 antibody conjugated with APC (10 vol%). ( L ) SSC versus APC fluorescence of particles from the same suspension as in ( K ). Particles gated as MV are indicated in blue.

    Article Snippet: Monoclonal human CD142 antibody conjugated to APC was from Miltenyi Biotec (Auburn, CA, USA).

    Techniques: Suspension, Incubation, Flow Cytometry, Staining, Fluorescence, Derivative Assay, Centrifugation

    Different expression in ovarian cancer cell lines. The expression levels of EGFR, Trop2, TF, and Her2 in ovarian cancer cell lines were determined by flow cytometry. The cells were treated with anti-EGFR (EGFR monoclonal antibody, H11), anti-Trop2 (Trop2 monoclonal antibody, MR54), anti-TF (CD142 antibody), and anti-Her2 (ErbB2 monoclonal antibody, 3B5) antibodies, respectively, followed by incubation with a secondary antibody (Goat anti-Mouse IgG Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 647). The cells were permeabilized to determine the Her2 expression according to manufacturer’s instructions.

    Journal: ACS Omega

    Article Title: SNAP-Tag-Based Antibody–Drug Conjugates Targeting Epidermal Growth Factor Receptor 1, Epidermal Growth Factor Receptor 2, Trophoblast Cell-Surface Antigen 2, and Tissue Factor for Ovarian Cancer Treatment

    doi: 10.1021/acsomega.5c10377

    Figure Lengend Snippet: Different expression in ovarian cancer cell lines. The expression levels of EGFR, Trop2, TF, and Her2 in ovarian cancer cell lines were determined by flow cytometry. The cells were treated with anti-EGFR (EGFR monoclonal antibody, H11), anti-Trop2 (Trop2 monoclonal antibody, MR54), anti-TF (CD142 antibody), and anti-Her2 (ErbB2 monoclonal antibody, 3B5) antibodies, respectively, followed by incubation with a secondary antibody (Goat anti-Mouse IgG Highly Cross-Adsorbed Secondary Antibody, Alexa Fluor Plus 647). The cells were permeabilized to determine the Her2 expression according to manufacturer’s instructions.

    Article Snippet: Briefly, 4 × 10 5 cells were collected and washed twice with PBS and then stained with anti-EGFR (H11, 0.5 μg, Thermo Fisher Scientific), anti-Trop2 (MR54, 1 μg, Thermo Fisher Scientific), or anti-TF (CD142, 10 μL, Miltenyi Biotec) antibodies in 200 μL of PBS for 30 min on ice.

    Techniques: Expressing, Flow Cytometry, Incubation